TrialJapanese journal of clinical oncology2014

Panitumumab in Japanese patients with unresectable colorectal cancer: a post-marketing surveillance study of 3085 patients.

Narikazu Boku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.